Zeke Capital Advisors’s BriaCell Therapeutics Corp. Warrant BCTXW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$92.7K Hold
45,000
0.01% 457
2022
Q3
$129K Hold
45,000
0.01% 446
2022
Q2
$117K Hold
45,000
0.01% 457
2022
Q1
$234K Hold
45,000
0.01% 440
2021
Q4
$211K Hold
45,000
0.01% 276
2021
Q3
$214K Hold
45,000
0.01% 270
2021
Q2
$81K Hold
45,000
0.01% 314
2021
Q1
$48K Buy
+45,000
New +$48K ﹤0.01% 289